Document is current

Any future updates will be listed below

First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis—results from a multicenter prospective randomized controlled trial and its post hoc analysis

Crossref DOI link: https://doi.org/10.1007/s00535-015-1102-z

Published Online: 2015-07-11

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark